医疗外设的首席执行官卖出股票, 但对冲基金买了更多的公司报告季度亏损. Outset Medical's CEO sold shares, but hedge funds bought more as the company reported a quarterly loss.

被淘汰的医学首席执行官Leslie Trigg, 最近出售股份, 将他的所有权削减了1.63%, Outset Medical's CEO, Leslie Trigg, recently sold shares, reducing his ownership by 1.63%, following earlier sales. 尽管进行了这些交易,但若干对冲基金增加了在该公司的持有量。 Despite these transactions, several hedge funds increased their holdings in the company. Outset Medical 报告称，季度亏损，低于分析师的预期。 Outset Medical reported a quarterly loss, missing analysts' expectations. 开发Tablo血液透析系统的公司获得了"行业绩效"评级, 目标价为3美元. The company, which develops the Tablo Hemodialysis System, received a "sector perform" rating with a $3 price target.